Search research articles
Contact Us
Filters
Showing results (451-460 of 594) with videos related to
Page
of 60
Sort By:
Journal of the National Cancer Institute
|
April 5, 2017
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer
Masanori Kawakami, Lisa Maria Mustachio, Jaime Rodriguez-Canales, et al.
Contemporary Clinical Trials
|
July 3, 2021
Alternative dosing of exemestane in postmenopausal women with ER-positive breast cancer. Design and methods of a randomized presurgical trial
Aliana Guerrieri-Gonzaga, Davide Serrano, Parjhitham Thomas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 3, 2021
Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC
Vincent K Lam, Jianjun Zhang, Carol C Wu, et al.
Journal for Immunotherapy of Cancer
|
February 23, 2022
ISA101 and nivolumab for HPV-16<sup>+</sup> cancer: updated clinical efficacy and immune correlates of response
Luana Guimaraes de Sousa, Kimal Rajapakshe, Jaime Rodriguez Canales, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
August 24, 2022
Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy
Meghna S Trivedi, Nadir Arber, Eitan Friedman, et al.
Cancers
|
March 13, 2024
Clinical Benefit from Docetaxel +/- Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Immunotherapy
Kang Qin, Kaiwen Wang, Shenduo Li, et al.
Annals of Surgery
|
September 2, 2022
High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed
Erin M Bayley, Megan L Ivy, Jitesh B Shewale, et al.
Nature Medicine
|
April 24, 2019
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
Jason K Sicklick, Shumei Kato, Ryosuke Okamura, et al.
Frontiers in Immunology
|
December 28, 2023
Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events
Mehmet Altan, Quan-Zhen Li, Qi Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 10, 2024
Multi-domain neurocognitive impairment following definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A cross-sectional study
James C H Chow, Jack Lee, Maria M P Lai, et al.
Page
of 60
Search research articles
Search
Showing results (451-460 of 594) with videos related to
Sort By:
Page
of 60
Journal of the National Cancer Institute
|
April 5, 2017
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer
Masanori Kawakami, Lisa Maria Mustachio, Jaime Rodriguez-Canales, et al.
Contemporary Clinical Trials
|
July 3, 2021
Alternative dosing of exemestane in postmenopausal women with ER-positive breast cancer. Design and methods of a randomized presurgical trial
Aliana Guerrieri-Gonzaga, Davide Serrano, Parjhitham Thomas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 3, 2021
Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC
Vincent K Lam, Jianjun Zhang, Carol C Wu, et al.
Journal for Immunotherapy of Cancer
|
February 23, 2022
ISA101 and nivolumab for HPV-16<sup>+</sup> cancer: updated clinical efficacy and immune correlates of response
Luana Guimaraes de Sousa, Kimal Rajapakshe, Jaime Rodriguez Canales, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
August 24, 2022
Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy
Meghna S Trivedi, Nadir Arber, Eitan Friedman, et al.
Cancers
|
March 13, 2024
Clinical Benefit from Docetaxel +/- Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Immunotherapy
Kang Qin, Kaiwen Wang, Shenduo Li, et al.
Annals of Surgery
|
September 2, 2022
High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed
Erin M Bayley, Megan L Ivy, Jitesh B Shewale, et al.
Nature Medicine
|
April 24, 2019
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
Jason K Sicklick, Shumei Kato, Ryosuke Okamura, et al.
Frontiers in Immunology
|
December 28, 2023
Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events
Mehmet Altan, Quan-Zhen Li, Qi Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 10, 2024
Multi-domain neurocognitive impairment following definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A cross-sectional study
James C H Chow, Jack Lee, Maria M P Lai, et al.
Page
of 60